Leolab
4.3|45 reviews
ID
Ismail D
1 reviews | Active since Member
21 Apr 2026, 09:13
⚠️ WARNING: LEOLAB Dangerous Reconstitution Supplies. Do not use
If you are buying peptides from Leolab, note that they are one of the most dangerous suppliers I have dealt with.
They send you items which, according to all research, SHOULD NOT BE USED to reconstitute the peptides. The water increases the risk of bacterial growth.
I ordered 3 vials of peptides. They sent me 1 vial of bacteriostatic water and 2 vials of sterile water. STERILE WATER LIKELY LEADS TO BACTERIAL GROWTH WITH MULTI-USE. IT IS NOT INTENDED FOR MULTIPLE USE, BUT RATHER SINGLE USE WITHIN A DAY.
Here is a quote (multiple sources state it is not suitable):
"Sterile water is primarily intended for single-dose applications, often packaged in small, single-use vials. Once the seal is broken, the water is immediately susceptible to microbial contamination from the surrounding air or the syringe used for withdrawal."
https://scienceinsights.org/can-i-use-sterile-water-instead-of-bacteriostatic-water/
This is the SECOND TIME this has occurred. In the last order, they sent saline water, which is also only meant for single use and does not stop bacterial growth.
If you are ordering from them ensure you confirm they are sending you BAC WATER, or make sure you get BAC Water, as it is not safe to be reconstituting with what they send you.
There are only a few peptidwa where the recommendation is to not use BAC WATER. oxytocin , desmopressin:, Vasopressin, HCG, GLP1
Helpful (0)
Replies (1)0
Replies (1)Leolab's replyOfficial
01 May 2026, 12:13First, please note that our company operates internationally (EU, US, UK, and South Africa), and all formulation-related decisions are reviewed by our scientific and medical board. These decisions are based on documented peptide chemistry, formulation science, and cumulative real-world data, not assumptions.
You are correct that your previous order included bacteriostatic water.
Since then, we have received multiple independent reports from clients that CJC-1295 + Ipamorelin reconstituted in bacteriostatic water becomes cloudy, forms aggregates or “gel-like” structures, shows reduced usability within days.
This does not occur in every case, as bacteriostatic water pH can vary between batches, but the pattern has been consistent enough to require action.
This behavior is fully consistent with known peptide chemistry, where benzyl alcohol (present in bacteriostatic water) and different pH environments can promote aggregation and physical instability in certain peptide formulations.
Based on this, we made a data-driven adjustment to supply sterile water, in order to preserve solution clarity, uniformity and dosing consistency.
This protocol refinement is based on observed outcomes.
The following are standard references in peptide/protein formulation science:
Wang, W. (1999). Instability, stabilization, and formulation of liquid protein pharmaceuticals
Manning et al. (2010). Stability of protein pharmaceuticals: an update
Arakawa et al. (2001). Protein stability and stabilizing excipients
These establish that preservatives such as benzyl alcohol can induce aggregation, peptide stability is highly dependent on pH and excipient environment, unsuitable diluents can lead to precipitation, structural instability, and loss of dosing reliability.
This is foundational pharmaceutical science, not somebody’s personal opinion.
Your statement that sterile water becomes “immediately unsafe” after first use is not accurate when taken out of context.
It is correct that sterile water contains no preservative and does not actively inhibit microbial growth
However, sterility is not lost instantly upon first puncture. Risk is introduced through incorrect handling, not automatically upon opening.
This is why, in both clinical and compounding settings, products reconstituted with sterile water are handled using aseptic technique, stored under refrigeration (2–8°C), used within a short time window
This is standard practice for many biologics. FDA Guidance: Sterile Drug Products Produced by Aseptic Processing and Product labeling for peptide drugs (e.g., tesamorelin), which specifies limited use periods after reconstitution, even without preservatives clearly demonstrate this rationale. Sterility is maintained through handling protocol, not only by preservatives.
There is no perfect diluent, unfortunately. This is always a balance between
Option A — Bacteriostatic water
antimicrobial protection
demonstrated aggregation and instability in this peptide blend
compromised dosing consistency
Option B — Sterile water
preserves physical integrity (clear, stable solution)
requires controlled handling due to lack of preservative
We selected Option B deliberately because a stable, non-aggregated solution is essential for accurate dosing and because a degraded or gelled solution is not acceptable, even if preserved.
When handled correctly refrigeration slows microbial growth, limited vial access reduces contamination risk, proper syringe technique maintains sterility to a practical degree.
Sterile water is not inherently unsafe when used correctly, bacteriostatic water is not universally suitable for all peptides, for CJC-Ipamorelin, bacteriostatic water has shown real-world instability issues. This is the reason why many peptide companies use sterile water exclusively with all their peptides.
— The LeoLab Team 🧡
You are correct that your previous order included bacteriostatic water.
Since then, we have received multiple independent reports from clients that CJC-1295 + Ipamorelin reconstituted in bacteriostatic water becomes cloudy, forms aggregates or “gel-like” structures, shows reduced usability within days.
This does not occur in every case, as bacteriostatic water pH can vary between batches, but the pattern has been consistent enough to require action.
This behavior is fully consistent with known peptide chemistry, where benzyl alcohol (present in bacteriostatic water) and different pH environments can promote aggregation and physical instability in certain peptide formulations.
Based on this, we made a data-driven adjustment to supply sterile water, in order to preserve solution clarity, uniformity and dosing consistency.
This protocol refinement is based on observed outcomes.
The following are standard references in peptide/protein formulation science:
Wang, W. (1999). Instability, stabilization, and formulation of liquid protein pharmaceuticals
Manning et al. (2010). Stability of protein pharmaceuticals: an update
Arakawa et al. (2001). Protein stability and stabilizing excipients
These establish that preservatives such as benzyl alcohol can induce aggregation, peptide stability is highly dependent on pH and excipient environment, unsuitable diluents can lead to precipitation, structural instability, and loss of dosing reliability.
This is foundational pharmaceutical science, not somebody’s personal opinion.
Your statement that sterile water becomes “immediately unsafe” after first use is not accurate when taken out of context.
It is correct that sterile water contains no preservative and does not actively inhibit microbial growth
However, sterility is not lost instantly upon first puncture. Risk is introduced through incorrect handling, not automatically upon opening.
This is why, in both clinical and compounding settings, products reconstituted with sterile water are handled using aseptic technique, stored under refrigeration (2–8°C), used within a short time window
This is standard practice for many biologics. FDA Guidance: Sterile Drug Products Produced by Aseptic Processing and Product labeling for peptide drugs (e.g., tesamorelin), which specifies limited use periods after reconstitution, even without preservatives clearly demonstrate this rationale. Sterility is maintained through handling protocol, not only by preservatives.
There is no perfect diluent, unfortunately. This is always a balance between
Option A — Bacteriostatic water
antimicrobial protection
demonstrated aggregation and instability in this peptide blend
compromised dosing consistency
Option B — Sterile water
preserves physical integrity (clear, stable solution)
requires controlled handling due to lack of preservative
We selected Option B deliberately because a stable, non-aggregated solution is essential for accurate dosing and because a degraded or gelled solution is not acceptable, even if preserved.
When handled correctly refrigeration slows microbial growth, limited vial access reduces contamination risk, proper syringe technique maintains sterility to a practical degree.
Sterile water is not inherently unsafe when used correctly, bacteriostatic water is not universally suitable for all peptides, for CJC-Ipamorelin, bacteriostatic water has shown real-world instability issues. This is the reason why many peptide companies use sterile water exclusively with all their peptides.
— The LeoLab Team 🧡
Best regards,
Leolab's reply01 May 2026, 12:13
Official
First, please note that our company operates internationally (EU, US, UK, and South Africa), and all formulation-related decisions are reviewed by our scientific and medical board. These decisions are based on documented peptide chemistry, formulation science, and cumulative real-world data, not assumptions.
You are correct that your previous order included bacteriostatic water.
Since then, we have received multiple independent reports from clients that CJC-1295 + Ipamorelin reconstituted in bacteriostatic water becomes cloudy, forms aggregates or “gel-like” structures, shows reduced usability within days.
This does not occur in every case, as bacteriostatic water pH can vary between batches, but the pattern has been consistent enough to require action.
This behavior is fully consistent with known peptide chemistry, where benzyl alcohol (present in bacteriostatic water) and different pH environments can promote aggregation and physical instability in certain peptide formulations.
Based on this, we made a data-driven adjustment to supply sterile water, in order to preserve solution clarity, uniformity and dosing consistency.
This protocol refinement is based on observed outcomes.
The following are standard references in peptide/protein formulation science:
Wang, W. (1999). Instability, stabilization, and formulation of liquid protein pharmaceuticals
Manning et al. (2010). Stability of protein pharmaceuticals: an update
Arakawa et al. (2001). Protein stability and stabilizing excipients
These establish that preservatives such as benzyl alcohol can induce aggregation, peptide stability is highly dependent on pH and excipient environment, unsuitable diluents can lead to precipitation, structural instability, and loss of dosing reliability.
This is foundational pharmaceutical science, not somebody’s personal opinion.
Your statement that sterile water becomes “immediately unsafe” after first use is not accurate when taken out of context.
It is correct that sterile water contains no preservative and does not actively inhibit microbial growth
However, sterility is not lost instantly upon first puncture. Risk is introduced through incorrect handling, not automatically upon opening.
This is why, in both clinical and compounding settings, products reconstituted with sterile water are handled using aseptic technique, stored under refrigeration (2–8°C), used within a short time window
This is standard practice for many biologics. FDA Guidance: Sterile Drug Products Produced by Aseptic Processing and Product labeling for peptide drugs (e.g., tesamorelin), which specifies limited use periods after reconstitution, even without preservatives clearly demonstrate this rationale. Sterility is maintained through handling protocol, not only by preservatives.
There is no perfect diluent, unfortunately. This is always a balance between
Option A — Bacteriostatic water
antimicrobial protection
demonstrated aggregation and instability in this peptide blend
compromised dosing consistency
Option B — Sterile water
preserves physical integrity (clear, stable solution)
requires controlled handling due to lack of preservative
We selected Option B deliberately because a stable, non-aggregated solution is essential for accurate dosing and because a degraded or gelled solution is not acceptable, even if preserved.
When handled correctly refrigeration slows microbial growth, limited vial access reduces contamination risk, proper syringe technique maintains sterility to a practical degree.
Sterile water is not inherently unsafe when used correctly, bacteriostatic water is not universally suitable for all peptides, for CJC-Ipamorelin, bacteriostatic water has shown real-world instability issues. This is the reason why many peptide companies use sterile water exclusively with all their peptides.
— The LeoLab Team 🧡
You are correct that your previous order included bacteriostatic water.
Since then, we have received multiple independent reports from clients that CJC-1295 + Ipamorelin reconstituted in bacteriostatic water becomes cloudy, forms aggregates or “gel-like” structures, shows reduced usability within days.
This does not occur in every case, as bacteriostatic water pH can vary between batches, but the pattern has been consistent enough to require action.
This behavior is fully consistent with known peptide chemistry, where benzyl alcohol (present in bacteriostatic water) and different pH environments can promote aggregation and physical instability in certain peptide formulations.
Based on this, we made a data-driven adjustment to supply sterile water, in order to preserve solution clarity, uniformity and dosing consistency.
This protocol refinement is based on observed outcomes.
The following are standard references in peptide/protein formulation science:
Wang, W. (1999). Instability, stabilization, and formulation of liquid protein pharmaceuticals
Manning et al. (2010). Stability of protein pharmaceuticals: an update
Arakawa et al. (2001). Protein stability and stabilizing excipients
These establish that preservatives such as benzyl alcohol can induce aggregation, peptide stability is highly dependent on pH and excipient environment, unsuitable diluents can lead to precipitation, structural instability, and loss of dosing reliability.
This is foundational pharmaceutical science, not somebody’s personal opinion.
Your statement that sterile water becomes “immediately unsafe” after first use is not accurate when taken out of context.
It is correct that sterile water contains no preservative and does not actively inhibit microbial growth
However, sterility is not lost instantly upon first puncture. Risk is introduced through incorrect handling, not automatically upon opening.
This is why, in both clinical and compounding settings, products reconstituted with sterile water are handled using aseptic technique, stored under refrigeration (2–8°C), used within a short time window
This is standard practice for many biologics. FDA Guidance: Sterile Drug Products Produced by Aseptic Processing and Product labeling for peptide drugs (e.g., tesamorelin), which specifies limited use periods after reconstitution, even without preservatives clearly demonstrate this rationale. Sterility is maintained through handling protocol, not only by preservatives.
There is no perfect diluent, unfortunately. This is always a balance between
Option A — Bacteriostatic water
antimicrobial protection
demonstrated aggregation and instability in this peptide blend
compromised dosing consistency
Option B — Sterile water
preserves physical integrity (clear, stable solution)
requires controlled handling due to lack of preservative
We selected Option B deliberately because a stable, non-aggregated solution is essential for accurate dosing and because a degraded or gelled solution is not acceptable, even if preserved.
When handled correctly refrigeration slows microbial growth, limited vial access reduces contamination risk, proper syringe technique maintains sterility to a practical degree.
Sterile water is not inherently unsafe when used correctly, bacteriostatic water is not universally suitable for all peptides, for CJC-Ipamorelin, bacteriostatic water has shown real-world instability issues. This is the reason why many peptide companies use sterile water exclusively with all their peptides.
— The LeoLab Team 🧡
Best regards,